In the TCGA cohort, CDKL3 expression was negatively correlated with the activity of step 4 of the cancer immunity cycles, i.e. immune cell trafficking to the tumor (Supplementary Figure 2A), which was further validated in the GSE47404 cohort (Supplementary Figure 2B). This evidence concerns the gene CDKL3 and neoplasm.